* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download document 8493486
Survey
Document related concepts
Middle East respiratory syndrome wikipedia , lookup
Bovine spongiform encephalopathy wikipedia , lookup
Bioterrorism wikipedia , lookup
Marburg virus disease wikipedia , lookup
Meningococcal disease wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Onchocerciasis wikipedia , lookup
Chagas disease wikipedia , lookup
Schistosomiasis wikipedia , lookup
Neglected tropical diseases wikipedia , lookup
Leptospirosis wikipedia , lookup
Leishmaniasis wikipedia , lookup
Visceral leishmaniasis wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Transcript
No paper available Theme: Aquaculture Session: WeA2 - Pests and deseases Title: Counting the current costs of salmonid disease free status in the UK Author(s): Abdulai Fofana , Dominic Moran Abstract: This paper describes the assumptions, scenarios and calculations underlying best estimates of the current costs of three notifiable fish diseases in the United Kingdom: infectious salmon anaemia (ISA), viral haemorrhagic septicaemia (VHS) and infectious haemorrhagic necrosis (IHN). The benefits of avoiding a major disease outbreak are effectively the return on spending to maintain disease free status. Current costs of salmonid disease freedom are the costs associated with the efforts of control, surveillance and monitoring activities from both the private and public sectors. The simulated effects of disease outbreak and avoidance costs on the public sector, domestic consumers, exporters are analysed and factored to generate estimates of maintaining disease freedom. The estimates of the average current costs of maintaining disease freedom per annum in the study period ranges between £13.5 million to £23.6 million per annum in total for all diseases. Individual current disease costs are substantially lower if specific expenditure is dedicated to the control and surveillance of the diseases in the private sector.